SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Coherus Oncology Files SEC Form

Coherus Oncology submits regulatory filing with the SEC. The filing is available for public review.

CHRS
SquawkNews Desk

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories

Nikkei futures extend losses, down 2.8% at 62,910 Nikkei futures were down 2.8% at 62,910, versus a 2.5% decline previously, after the BOJ outcome. M impact | EQUITY | Oct 30, 2026, 03:07 AM UTC Nikkei Futures Extend Decline, Down 2.9% After BOJ Decision M impact | EQUITY | Oct 30, 2026, 03:07 AM UTC Q2 Results Live Updates: Suzlon, Trent react to numbers; RIL, Sun Pharma, BEL, report today Q2 Results Live Updates: The final trading day of the week will bring in a plethora of result reactions and plenty of earnings as well from Nifty 50 and broader market companies. R H impact | EQUITY | Oct 30, 2026, 03:06 AM UTC BOJ to Sell ETF Holdings at About 0.1% of Market Trading Value M impact | EQUITY | Oct 30, 2026, 03:03 AM UTC Nikkei Futures Down 2.6% After BOJ Decision Nikkei futures were last down 2.6%, largely unmoved by the BOJ decision. M impact | EQUITY | Oct 30, 2026, 03:03 AM UTC Asian session market picture: S&P 500 -0.99%, Nasdaq 100 -2.2%; USD/JPY -0.12%, WTI +1.28%, 1810 leads volume Asian session market picture. US index futures: S and P futures is down 0.99 percent, Nasdaq futures is down 2.2 percent, Dow futures is down 0.16 percent and Russell futures is do M impact | EQUITY | Oct 30, 2026, 03:00 AM UTC